Regeneron Pharmaceuticals
Utility Patents
Last updated:
List of all Regeneron Pharmaceuticals patents 248 in total
| Status | Patent |
|---|---|
Grant | Utility: Genetic modification of rats Filling date: 12 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Production of fertile XY female animals by silencing of genes on the Y chromosome Filling date: 12 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Genetically modified mouse whose genome comprises a humanized CD274 gene Filling date: 12 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Non-human animals that make single domain binding proteins Filling date: 12 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: High affinity human antibodies to human angiopoietin-2 Filling date: 12 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Syringe systems, piston seal systems, stopper systems, and methods of use and assembly Filling date: 12 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Rodents having a humanized TMPRSS gene Filling date: 12 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Formulations of VEG antagonist fusion proteins and method of manufacturing them Filling date: 12 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof Filling date: 12 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Anti-CTLA-4 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Non-human animals having an engineered immunoglobulin .LAMBDA. light chain locus Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Humanized T cell co-receptor mice Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Methods of treating inflammatory conditions Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof Filling date: 12 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Human antibodies to Bet v 1 and methods of use thereof Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Methods and compositions for targeted genetic modifications and methods of use Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: V.sub.L antigen binding proteins exhibiting distinct binding characteristics Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: HSD17B13 variants and uses thereof Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Humanized M-CSF mice Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Genetically modified major histocompatibility complex animals Filling date: 12 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus Filling date: 12 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: IL-33 antagonists and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Humanized model of kidney and liver disorders Filling date: 12 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Rotatable surgical table Filling date: 12 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Anti-TIE2 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Stabilized formulations containing anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Method for generating high affinity antibodies Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Method of treating osteoarthritis with an antibody to NGF Filling date: 12 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Anti-EGFRvIII antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: B4GALT1 cDNA variants and compositions comprising the same Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Human antibodies to PD-1 Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Method of averting opioid addiction Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Anti-GITR antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Anti-CD8 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor Filling date: 12 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: System and method for characterizing protein dimerization Filling date: 12 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Methods and compositions for the targeted modification of a mouse ES cell genome Filling date: 12 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Steroids and protein-conjugates thereof Filling date: 12 Sep 2025 Issue date: 14 Jul 2020 |
Showing 100 to 150 of 248 patents.